Showing results (281-290 of 666) with videos related to
Sort By:
Pageof 67
Nutrients|June 28, 2023
Full Breastfeeding and Allergic Diseases-Long-Term Protection or Rebound Effects?Lars Libuda, Birgit Filipiak-Pittroff, Marie Standl, et al.Frontiers in Oncology|April 22, 2025
Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusionNadja Ballin, Alexander Ott, Olga Seibel-Kelemen, et al.Langmuir : the ACS Journal of Surfaces and Colloids|July 23, 2015
Highly Sensitive Detection of Surface and Intercalated Impurities in Graphene by LEISStanislav Průša, Pavel Procházka, Petr Bábor, et al.European Heart Journal|August 11, 2004
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trialThomas Fetsch, Peter Bauer, Rolf Engberding, et al.Journal of Medical Genetics|November 5, 2014
EIF4G1 is neither a strong nor a common risk factor for Parkinson's disease: evidence from large European cohortsJohanna Huttenlocher, Rejko Krüger, Philipp Capetian, et al.Bioanalysis|February 4, 2022
Lysosphingolipid urine screening test using mass spectrometry for the early detection of lysosomal storage disordersMarcel A Kelkel, Michel Boutin, Filipa Curado, et al.International Journal of Hygiene and Environmental Health|November 5, 2013
The associations between traffic-related air pollution and noise with blood pressure in children: results from the GINIplus and LISAplus studiesChuang Liu, Elaine Fuertes, Carla M T Tiesler, et al.Prenatal Diagnosis|December 17, 2021
High rate of abnormal findings in Prenatal Exome Trio in low risk pregnancies and apparently normal fetusesNoam Vaknin, Noy Azoulay, Erez Tsur, et al.International Journal of Molecular Sciences|May 13, 2026
Glucosylsphingosine (Lyso-Gb1) Dynamics in Untreated States in Gaucher DiseaseTama Dinur, Peter Bauer, Sabine Schroeder, et al.Journal of Cancer Research and Clinical Oncology|February 22, 2022
TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapyJulia Eckardt, Christopher Schroeder, Peter Martus, et al.Pageof 67